Companies Dominating the Inhaled Nitric Oxide Delivery Systems Landscape
- Mallinckrodt Pharmaceuticals
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Getinge
- Vero Biotech
- LINDE
- Beyond Air
- SLE
- NU MED
- Bellerophon Therapeutics
- Circassia Pharmaceuticals
- Air Liquide Healthcare
Browse Key Market Insights with Data Illustration:
In the News
- The most up to date emphasis of VERO Biotech, Inc.'s tankless inhaled nitric oxide delivery systems gotten FDA endorsement. VERO Biotech, Inc. may be a commercial-stage healthcare company committed to the neonatal seriously care and intense care healing center community. The special highlights of the company's third era GENOSYL nitric oxide delivery systems permit quicker dosing, disentangled dealing with and more effective operation.
- Mallinckrodt Pharmaceuticals received permission from the Canadian regulatory authorities to use its NO delivery systems for COVID-19 patients.
